This inventor holds 2 USPTO granted patents. Top assignee: Shandong University of Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Md Ahsanul Kabir Khan: Innovator in Genetic Engineering
Introduction
Md Ahsanul Kabir Khan is a prominent inventor based in ZiBo, China. He has made significant contributions to the field of genetic engineering, particularly in the production of essential fatty acids through innovative fermentation technologies. His work has led to the development of two notable patents.
Latest Patents
Md Ahsanul Kabir Khan's latest patents include a construction method of a cell factory for producing dihomo-gamma-linolenic acid and a fermentation technology. This invention involves cloning the gamma-linolenic acid elongase gene, which is then ligated to an integrative plasmid and transformed into a defective strain. The resulting recombinant strain exhibits a significant change in lipid composition, achieving a dihomo-gamma-linolenic acid content of 5.7% of total fatty acids under optimized fermentation conditions.
His second patent focuses on the construction of a cell factory for producing stearidonic acid. This process also involves cloning a specific desaturase gene and integrating it into the genome of a defective strain. The new recombinant strain has been classified and deposited with an accession number, further validating the innovation.
Career Highlights
Md Ahsanul Kabir Khan is affiliated with Shandong University of Technology, where he continues to advance research in genetic engineering. His work has garnered attention for its potential applications in biotechnology and health.
Collaborations
He has collaborated with notable colleagues, including Wu Yang and Junhuan Yang, contributing to the success of his research endeavors.
Conclusion
Md Ahsanul Kabir Khan's innovative work in genetic engineering exemplifies the impact of scientific research on the production of essential fatty acids. His patents reflect a commitment to advancing biotechnology and improving health outcomes through genetic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile